Speak directly to the analyst to clarify any post sales queries you may have.
The brain imaging modalities market is responding to evolving clinical and operational objectives as healthcare providers seek advanced diagnostics and improved workflow efficiency. Senior decision-makers are increasingly focused on integrating innovative technologies and flexible solutions to enable accurate, timely care across diverse healthcare settings.
Market Snapshot: Growth in the Brain Imaging Modalities Market
The brain imaging modalities market is valued at USD 10.99 billion in 2024 and is expected to reach USD 11.71 billion in 2025, with a projected compound annual growth rate (CAGR) of 6.58%, reaching USD 18.32 billion by 2032. This sustained growth trajectory reflects the market’s response to ongoing clinical innovation, technology adoption, and evolving reimbursement models. As competitive pressures grow, industry stakeholders are strategically investing in enhanced imaging systems and streamlined workflows to improve both patient care and organizational resilience.
Scope & Segmentation: Comprehensive Market Coverage
This report provides senior executives with end-to-end insights into the entire brain imaging modalities ecosystem. The segmentation framework supports benchmarking and informs strategic choices by covering:
- Modality: Covers computed tomography (cone beam, conventional), magnetic resonance imaging (angiography, diffusion, functional, structural), optical imaging (Fnirs, optical coherence tomography), positron emission tomography (amyloid, dopamine, FDG), single photon emission computed tomography (dopamine transporter), and ultrasound imaging (biomicroscopy, transcranial Doppler). These modalities are enabling more specialized and scalable clinical workflows, promoting ongoing technology innovation.
- Application: Encompasses diagnostics for epilepsy, neurodegenerative diseases, brain injuries, tumor evaluation, and vascular assessments. Expands to research use cases, including brain mapping, neuroscience studies, drug development, and therapy monitoring, allowing organizations to support both clinical care and scientific advancement.
- End User: Reflects implementation trends in academic institutions, ambulatory care, diagnostic centers, home healthcare organizations, hospitals, and research institutes in public and private sectors. This analysis aids in understanding technology deployment and operational requirements across diverse settings.
- Geographic Regions: Examines the Americas, Europe/Middle East/Africa, and Asia Pacific, focusing on local market dynamics, infrastructure maturity, and policy influences shaping opportunity and risk profiles for market entrants and incumbents.
- Corporate Analysis: Details Siemens Healthineers AG, General Electric Company, Koninklijke Philips N.V., Canon Inc., Hitachi Ltd., Fujifilm Holdings Corporation, Shimadzu Corporation, Neusoft Medical Systems Co., Ltd., Samsung Electronics Co., Ltd., and Bruker Corporation. Senior leaders receive up-to-date competitive insights and innovation monitoring for effective strategy planning.
Key Takeaways: Strategic Insights for Decision-Makers
- Continuous advancements in brain imaging hardware and analytics, including artificial intelligence, are raising expectations for diagnostic precision and operational effectiveness in neurological care.
- Integration of multimodal platforms supports holistic approaches by aggregating patient data for deeper clinical insights and more comprehensive care pathways.
- Portable and cloud-enabled imaging technologies are increasing access to diagnostics in decentralized environments, supporting remote monitoring and enabling home-based care strategies.
- Regional diversification—through local manufacturing and cross-border research—helps organizations manage regulatory and supply chain risks while staying responsive to market fluctuations.
- Collaboration among device manufacturers and data analytics experts accelerates product validation timelines and broadens available service portfolios, allowing stakeholders to remain agile in a shifting landscape.
- Adopting modular system architectures and flexible procurement models strengthens organizations’ ability to address regulatory demands and adapt to changing clinical requirements.
Tariff Impact: Policy Changes and Supply Chain Adaptation
Following the introduction of US tariffs in 2025, companies in the brain imaging modalities market reevaluated sourcing strategies and diversified logistics networks to control costs. Expanding local vendor relationships and enhancing domestic production capacity have contributed to a shift toward modular systems, more strategic procurement processes, and increased regional self-sufficiency for essential supplies.
Methodology & Data Sources
This analysis is grounded in primary interviews with experts, detailed literature review, review of regulatory changes and patent activity, and structured quantitative forecasting. By integrating primary and secondary data sources, the report delivers robust recommendations for forward-looking strategies.
Why This Report Matters for Stakeholders
- Enables senior leaders and investors to efficiently allocate resources to technology areas and regions with the highest growth and strategic potential.
- Provides actionable recommendations that incorporate competitor, regulatory, and supply chain analysis to inform confident decision-making at the executive level.
- Equips organizations to anticipate and mitigate procurement, compliance, and operational risks, strengthening business continuity and elevating standards in healthcare delivery.
Conclusion
Organizations that prioritize advanced imaging technologies, modular approaches, and regional adaptation can better respond to industry shifts. These strategic insights support the development of agile strategies suited to evolving healthcare market demands.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Samples

LOADING...
Companies Mentioned
The key companies profiled in this Brain Imaging Modalities market report include:- Siemens Healthineers AG
- General Electric Company
- Koninklijke Philips N.V.
- Canon Inc.
- Hitachi Ltd.
- Fujifilm Holdings Corporation
- Shimadzu Corporation
- Neusoft Medical Systems Co., Ltd.
- Samsung Electronics Co., Ltd.
- Bruker Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 181 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 11.71 Billion |
| Forecasted Market Value ( USD | $ 18.32 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |

